COM:ROYALTYPHARMA
Royalty Pharma
- Stock
Last Close
26.22
21/11 21:00
Market Cap
11.73B
Beta: -
Volume Today
3.03M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 9.60M - | 328.57M 3,323.30% | 328.57M 0% | 0.50 - | ||||
average payables | 7.83M - | 10.98M 40.23% | 8.20M 25.31% | 6.76M 17.50% | 11.54M 70.57% | |||
average receivables | 118.70M - | 38.97M 67.17% | 53.74M 37.91% | 52.45M 2.39% | 405.84M 673.72% | |||
book value per share | 12.67 - | 17.24 36.04% | 26.36 52.90% | 13.93 47.16% | 12.85 7.72% | 10.83 15.76% | ||
capex per share | 0.76 - | 5.85 - | 0.00 99.98% | 4.66 369,531.27% | -3.51 175.29% | |||
capex to depreciation | 8.10 - | 95.28 - | 0.02 99.98% | 359.99 1,582,761.44% | ||||
capex to operating cash flow | 0.17 - | 1.08 - | 0.00 99.98% | 0.95 367,160.50% | -0.70 173.30% | |||
capex to revenue | 0.15 - | 1.04 - | 0.00 99.98% | 0.91 399,292.19% | -0.90 198.48% | |||
cash per share | 6.74 - | 2.24 66.76% | 5.31 136.90% | 6.76 27.38% | 5.54 17.98% | 0.82 85.18% | ||
days of inventory on hand | 51.53 - | 2.72K - | ||||||
days payables outstanding | 12.02 - | 44.64 - | 89.20 99.85% | 508.94 470.54% | ||||
days sales outstanding | 40.39 - | 7.80 80.69% | 6.74 13.62% | 10.89 61.65% | 5.97 45.17% | 120.15 1,912.35% | ||
debt to assets | 0.57 - | 0.50 12.61% | 0.28 44.98% | 0.41 46.94% | 0.42 4.47% | 0.37 11.51% | ||
debt to equity | 1.45 - | 1.02 29.66% | 0.59 42.47% | 1.23 109.00% | 1.26 2.93% | 0.94 25.65% | ||
dividend yield | 0.05 - | 0.05 10.77% | 0.05 9.22% | 0.02 54.96% | 0.02 18.34% | 0.02 11.62% | 0.02 9.87% | |
earnings yield | 0.08 - | 0.09 13.86% | 0.15 70.46% | 0.03 80.18% | 0.03 1.94% | 0.00 91.46% | 0.07 2,607.83% | |
enterprise value | 20.36B - | 21.72B 6.68% | 23.60B 8.67% | 22.08B 6.42% | 22.71B 2.85% | 22.59B 0.53% | ||
enterprise value over ebitda | 14.40 - | 8.23 42.82% | 12.54 52.29% | 14.90 18.84% | 23.10 55.04% | 15.14 34.46% | ||
ev to operating cash flow | 12.58 - | 13.02 3.55% | 11.60 10.95% | 10.95 5.62% | 10.59 3.22% | 7.45 29.65% | ||
ev to sales | 11.34 - | 11.97 5.54% | 11.12 7.09% | 9.65 13.26% | 10.15 5.25% | 9.60 5.49% | ||
free cash flow per share | 4.00 - | 5.33 33.11% | 4.71 11.69% | 11.27 139.43% | 4.87 56.83% | 9.56 96.41% | 1.52 84.10% | |
free cash flow yield | 0.09 - | 0.12 33.11% | 0.11 11.69% | 0.23 112.88% | 0.12 45.79% | 0.24 98.05% | 0.05 77.63% | |
graham net net | -12.07 - | -15.49 28.38% | -10.05 35.10% | -10.64 5.83% | -11.03 3.72% | -8.66 21.52% | ||
graham number | 33.30 - | 50.71 52.28% | 29.61 41.62% | 19.02 35.77% | 5.32 72.04% | 21.41 302.65% | ||
income quality | 1.06 - | 1.07 0.97% | 0.68 36.47% | 1.20 76.49% | 1.63 35.97% | 9.32 473.31% | 2.67 71.33% | |
intangibles to total assets | 0 - | 0.01 Infinity% | 0.00 37.56% | 0.00 67.29% | 0.00 76.18% | 0 100% | 0 | |
interest coverage | 3.80 - | 4.87 28.28% | 9.77 100.40% | 10.16 4.01% | 8.61 15.24% | 5.20 39.61% | 7.97 53.28% | |
interest debt per share | 19.20 - | 18.37 4.30% | 15.91 13.39% | 17.51 10.04% | 16.68 4.74% | 10.49 37.12% | ||
inventory turnover | 7.08 - | 0.13 - | ||||||
invested capital | 1.45 - | 1.02 29.66% | 0.59 42.47% | 1.23 109.00% | 1.26 2.93% | 0.94 25.65% | ||
market cap | 15.76B - | 15.76B 0% | 15.76B 0% | 18.79B 19.23% | 16.53B 12.03% | 17.31B 4.71% | 16.94B 2.15% | |
net current asset value | -4.21B - | -5.48B 30.10% | -3.43B 37.42% | -4.39B 28.07% | -4.73B 7.84% | -5.02B 6.13% | ||
net debt to ebitda | 3.25 - | 2.26 30.54% | 2.55 13.14% | 3.75 46.73% | 5.50 46.69% | 3.79 31.03% | ||
net income per share | 3.42 - | 3.89 13.86% | 6.63 70.46% | 1.48 77.71% | 1.15 21.92% | 0.10 91.53% | 1.88 1,824.67% | |
operating cash flow per share | 4.00 - | 4.57 14.10% | 4.71 3.02% | 5.42 15.12% | 4.86 10.25% | 4.90 0.65% | 5.03 2.72% | |
payables turnover | 30.37 - | 8.18 - | 4.09 49.96% | 0.72 82.47% | ||||
receivables turnover | 9.04 - | 46.80 417.90% | 54.18 15.77% | 33.52 38.14% | 61.13 82.39% | 3.04 95.03% | ||
research and ddevelopement to revenue | 0.07 - | 0.22 196.55% | 0.05 79.08% | 0.01 73.23% | 0.09 613.26% | 0.08 9.42% | 0.02 72.10% | |
return on tangible assets | 0.12 - | 0.19 55.29% | 0.03 86.09% | 0.03 3.79% | 0.00 90.68% | 0.07 2,619.31% | ||
revenue per share | 4.51 - | 5.07 12.33% | 5.12 1.08% | 5.65 10.34% | 5.52 2.34% | 5.11 7.45% | 3.91 23.55% | |
roe | 0.31 - | 0.38 25.31% | 0.06 85.42% | 0.08 47.78% | 0.01 90.82% | 0.17 2,184.81% | ||
roic | 0.09 - | 0.18 105.90% | 0.03 81.85% | 0.04 29.51% | 0.01 66.69% | 0.08 450.89% | ||
sales general and administrative to revenue | 0.07 - | 0.03 48.22% | 0.06 65.31% | 0.09 50.43% | 0.08 6.89% | 0.10 27.23% | 0.11 4.40% | |
shareholders equity per share | 12.67 - | 17.24 36.04% | 26.36 52.90% | 13.93 47.16% | 12.85 7.72% | 10.83 15.76% | ||
stock based compensation to revenue | 0.00 - | 0.00 58.28% | 0.00 9.10% | 0.00 3.20% | ||||
tangible asset value | 4.48B - | 6.09B 36.04% | 14.94B 145.40% | 10.24B 31.46% | 9.53B 7.00% | 10.08B 5.87% | ||
tangible book value per share | 12.64 - | 17.19 36.04% | 39.80 131.50% | 24.69 37.96% | 21.75 11.92% | 16.73 23.09% | ||
working capital | 2.03B - | 498.65M 75.42% | 2.39B 379.09% | 2.71B 13.31% | 1.39B 48.72% | 1.11B 19.83% |
All numbers in (except ratios and percentages)